Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tonny Jensen

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Current Medical Research and Opinion|June 22, 2016
Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemiaUlrik Pedersen-Bjergaard, Peter Lommer Kristensen, Kirsten Nørgaard, et al.
BMJ Open|October 9, 2014
Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping of blood pressure during night time: protocol for a randomised, placebo-controlled, double-blind, two-way crossover studyHenrik Hjortkær, Tonny Jensen, Klaus Kofoed, et al.
Journal of Diabetes and Its Complications|October 26, 2018
Left ventricular remodelling and cardiac chamber sizes in long-term, normoalbuminuric type 1 diabetes patients with and without cardiovascular autonomic neuropathyHenrik Ø Hjortkjær, Tonny Jensen, Jannik Hilsted, et al.
Diabetes|April 14, 2012
Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patientsUlrik Madvig Mogensen, Tonny Jensen, Lars Køber, et al.
Diabetes Research and Clinical Practice|April 22, 2018
Possible early detection of coronary artery calcium progression in type 1 diabetes: A case-control study of normoalbuminuric type 1 diabetes patients and matched controlsHenrik Ø Hjortkjær, Tonny Jensen, Jannik Hilsted, et al.
Diabetes Technology & Therapeutics|March 23, 2018
Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna TrialRikke Mette Agesen, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.
Diabetes Research and Clinical Practice|December 25, 2016
The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trialUlrik Pedersen-Bjergaard, Peter L Kristensen, Henning Beck-Nielsen, et al.
BMJ Open|December 7, 2016
Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping: a randomised, placebo-controlled, double-blind cross-over trialHenrik Øder Hjortkjær, Tonny Jensen, Klaus F Kofoed, et al.
Diabetes Research and Clinical Practice|December 4, 2014
Myocardial perfusion at rest in patients with Diabetes Mellitus Type 1 compared with healthy controls assessed with Multi Detector Computed TomographyChristina Byrne, Tonny Jensen, Henrik Øder Hjortkjær, et al.
BMJ Open|April 30, 2013
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention studyThomas Idorn, Filip K Knop, Morten Jørgensen, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Current Medical Research and Opinion|June 22, 2016
Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemiaUlrik Pedersen-Bjergaard, Peter Lommer Kristensen, Kirsten Nørgaard, et al.
BMJ Open|October 9, 2014
Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping of blood pressure during night time: protocol for a randomised, placebo-controlled, double-blind, two-way crossover studyHenrik Hjortkær, Tonny Jensen, Klaus Kofoed, et al.
Journal of Diabetes and Its Complications|October 26, 2018
Left ventricular remodelling and cardiac chamber sizes in long-term, normoalbuminuric type 1 diabetes patients with and without cardiovascular autonomic neuropathyHenrik Ø Hjortkjær, Tonny Jensen, Jannik Hilsted, et al.
Diabetes|April 14, 2012
Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patientsUlrik Madvig Mogensen, Tonny Jensen, Lars Køber, et al.
Diabetes Research and Clinical Practice|April 22, 2018
Possible early detection of coronary artery calcium progression in type 1 diabetes: A case-control study of normoalbuminuric type 1 diabetes patients and matched controlsHenrik Ø Hjortkjær, Tonny Jensen, Jannik Hilsted, et al.
Diabetes Technology & Therapeutics|March 23, 2018
Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna TrialRikke Mette Agesen, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.
Diabetes Research and Clinical Practice|December 25, 2016
The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trialUlrik Pedersen-Bjergaard, Peter L Kristensen, Henning Beck-Nielsen, et al.
BMJ Open|December 7, 2016
Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping: a randomised, placebo-controlled, double-blind cross-over trialHenrik Øder Hjortkjær, Tonny Jensen, Klaus F Kofoed, et al.
Diabetes Research and Clinical Practice|December 4, 2014
Myocardial perfusion at rest in patients with Diabetes Mellitus Type 1 compared with healthy controls assessed with Multi Detector Computed TomographyChristina Byrne, Tonny Jensen, Henrik Øder Hjortkjær, et al.
BMJ Open|April 30, 2013
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention studyThomas Idorn, Filip K Knop, Morten Jørgensen, et al.
Pageof 3